CVS Health Corp vs KraneShares CSI China Internet ETF — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while KraneShares CSI China Internet ETF trades at $24.5 (market cap $4.46B). The key difference: CVS Health Corp is far larger — about 25.2× KraneShares CSI China Internet ETF's market cap, and CVS Health Corp pays a 3.02% dividend while KraneShares CSI China Internet ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| CVS | KWEB | |
|---|---|---|
Market Cap | $112.49B | $4.46B |
Volume | 8,467,392 | 11,090,451 |
Sector | Health | Sector/Thematic |
52-Week High | $110.60 | $41.35 |
52-Week Low | $70.08 | $23.63 |
Typical Hold Time | 83 Days | 57 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
KWEB trades at $24.33, down 0.86% with a bearish technical signal. Moving averages indicate selling pressure, while oscillators are neutral. Support and resistance cluster around $24-$25. Recent news highlights U.S.-China trade dynamics and institutional stake changes, with mixed sentiment on Chinese internet stocks amid economic rebalancing talks.
The outlook remains cautious due to geopolitical risks and weak technicals. Opportunities exist if trade tensions ease, but risks include Chinese regulatory shifts and global protectionism. Investor sentiment is divided, with some institutions reducing exposure while others accumulate, reflecting uncertainty in China's economic trajectory.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →